Latest filing published 18 Aug 2026 for BIO-TECHNE Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James Hippel, listed as finance chief, appears in our data through filings on BIO-TECHNE Corp shares, published by SEC (Form 4). We count 76 filings; the first trade dates from 31 March 2016 and the latest from 15 August 2026.
On the market, this insider has only sold: 34 sales, €25.6M in total. The rest of the record consists of 12 share grants and 30 option exercises.
The record was last updated on 18 August 2026 with an option exercise in BIO-TECHNE Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations